Form 4 for APVO Aptevo Therapeutics Inc.

Accepted 2022-06-03 00:00:00 ET · period of report 2022-06-01 · accession 0001209191-22-033930 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-06-03	2022-06-01	APVO	Harsanyi Zsolt	Dir	M - OptEx	—	+298	4,607	+7%	—
D	2022-06-03	2022-06-01	APVO	Harsanyi Zsolt	Dir	M - OptEx	$0.00	-298	595	-33%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-06-01	M	A	298	—	4,607	D	—	—	(F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) Shares beneficially owned by the reporting person were adjusted to include the following shares of the Issuer's common stock: (i) 210 shares that were inadvertently omitted from the Form 4 filed on August 5, 2016; and (ii) 527 shares that were originally disclosed in the Form 4 filed on August 5, 2016, but due to a mathematical error, were not included in the aggregate number of shares beneficially owned in the Form 4 filed on June 7, 2019. In each of subsections (i) and (ii) above, the number of shares were adjusted to reflect a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020.
2	Derivative	Restricted Stock Unit	2022-06-01	M	D	298	$0.00	595	D	— · — to —	298 Common Stock	(F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F3) On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.